Euroapi SAS
PAR:EAPI
Euroapi SAS
Other Equity
Euroapi SAS
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
Euroapi SAS
PAR:EAPI
|
Other Equity
€188.4m
|
CAGR 3-Years
102%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sanofi SA
PAR:SAN
|
Other Equity
€74.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ipsen SA
PAR:IPN
|
Other Equity
€98.8m
|
CAGR 3-Years
82%
|
CAGR 5-Years
32%
|
CAGR 10-Years
14%
|
|
|
Vetoquinol SA
PAR:VETO
|
Other Equity
-€19.2m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-9%
|
|
|
Virbac SA
PAR:VIRP
|
Other Equity
€1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Medincell SA
PAR:MEDCL
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Euroapi SAS
Glance View
EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
See Also
What is Euroapi SAS's Other Equity?
Other Equity
188.4m
EUR
Based on the financial report for Dec 31, 2024, Euroapi SAS's Other Equity amounts to 188.4m EUR.
What is Euroapi SAS's Other Equity growth rate?
Other Equity CAGR 3Y
102%
Over the last year, the Other Equity growth was 2 755%. The average annual Other Equity growth rates for Euroapi SAS have been 102% over the past three years .
You don't have any saved screeners yet